Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors

Tsuyoshi Sakoda, Noriyuki Kasahara, Larry Kedes, Mitsumasa Ohyanagi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV, lentivirus) vector has attractive features for gene therapy, including the ability to transduce non-dividing cells and long-term transgene expression. We have already reported that lentivirus vector can transduce well-differentiated rat cardiac myocytes. Endothelial cells (EC) are an attractive target for gene therapy, both for the treatment of cardiovascular disease and for the systemic delivery of recombinant gene products directly into the circulation. There are several reports regarding application of adenovirus and retrovirus based vectors to EC. However, there have been few reports which show the effect to lentivirus-mediated gene transfer efficiency, compared with adenovirus and retrovirus. In this study, bovine aortic endothelial cells (BAECs) were infected, in vitro, with these virus vectors. Transduction efficiency (TE) of β-Gal gene transfer in BAECs by adenovirus, lentivirus, or retrovirus at MOI10 (Multiplicity of infection) (determined on Hela cells) is 69±11, 33±8, or 22±6% respectively. In adenovirus and lentivirus, almost 100% of BAECs were transduced at MOI 50. However, in retrovirus, TE showed only 48±6% at MOI 50 and no increase at MOI 100. The percentage of β-Gal positive cells was decreased rapidly at longer passage of cells after being transduced by adenovirus. However, lentivirus and retrovirus showed sustained higher percentage of positive cells. Furthermore, transduction by lentiviral vectors had no significant effect on viability of BAECs. Our results indicate that lentivirus showed high-level and long term gene expression in BAECs. Lentivirus can be an effective vector for the ex vivo, genetically modified EC implantation and in vivo gene therapy.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalPreparative Biochemistry and Biotechnology
Volume37
Issue number1
DOIs
StatePublished - Jan 18 2007
Externally publishedYes

Fingerprint

Gene transfer
Lentivirus
Endothelial cells
Endothelial Cells
Retroviridae
Adenoviridae
Gene therapy
Genes
Genetic Therapy
Viruses
Cells
HIV
Transgenes
HeLa Cells
Cardiac Myocytes
Gene expression
Rats
Cardiovascular Diseases
Gene Expression

Keywords

  • Adenovirus
  • Endotherial cells
  • Gene therapy
  • Lentivirus
  • Retrovirus

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Molecular Biology
  • Applied Microbiology and Biotechnology

Cite this

Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors. / Sakoda, Tsuyoshi; Kasahara, Noriyuki; Kedes, Larry; Ohyanagi, Mitsumasa.

In: Preparative Biochemistry and Biotechnology, Vol. 37, No. 1, 18.01.2007, p. 1-11.

Research output: Contribution to journalArticle

@article{7e4d975688de4abf9a2ff3b69f5af027,
title = "Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors",
abstract = "Human immunodeficiency virus (HIV, lentivirus) vector has attractive features for gene therapy, including the ability to transduce non-dividing cells and long-term transgene expression. We have already reported that lentivirus vector can transduce well-differentiated rat cardiac myocytes. Endothelial cells (EC) are an attractive target for gene therapy, both for the treatment of cardiovascular disease and for the systemic delivery of recombinant gene products directly into the circulation. There are several reports regarding application of adenovirus and retrovirus based vectors to EC. However, there have been few reports which show the effect to lentivirus-mediated gene transfer efficiency, compared with adenovirus and retrovirus. In this study, bovine aortic endothelial cells (BAECs) were infected, in vitro, with these virus vectors. Transduction efficiency (TE) of β-Gal gene transfer in BAECs by adenovirus, lentivirus, or retrovirus at MOI10 (Multiplicity of infection) (determined on Hela cells) is 69±11, 33±8, or 22±6{\%} respectively. In adenovirus and lentivirus, almost 100{\%} of BAECs were transduced at MOI 50. However, in retrovirus, TE showed only 48±6{\%} at MOI 50 and no increase at MOI 100. The percentage of β-Gal positive cells was decreased rapidly at longer passage of cells after being transduced by adenovirus. However, lentivirus and retrovirus showed sustained higher percentage of positive cells. Furthermore, transduction by lentiviral vectors had no significant effect on viability of BAECs. Our results indicate that lentivirus showed high-level and long term gene expression in BAECs. Lentivirus can be an effective vector for the ex vivo, genetically modified EC implantation and in vivo gene therapy.",
keywords = "Adenovirus, Endotherial cells, Gene therapy, Lentivirus, Retrovirus",
author = "Tsuyoshi Sakoda and Noriyuki Kasahara and Larry Kedes and Mitsumasa Ohyanagi",
year = "2007",
month = "1",
day = "18",
doi = "10.1080/10826060601039345",
language = "English (US)",
volume = "37",
pages = "1--11",
journal = "Preparative Biochemistry and Biotechnology",
issn = "1082-6068",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors

AU - Sakoda, Tsuyoshi

AU - Kasahara, Noriyuki

AU - Kedes, Larry

AU - Ohyanagi, Mitsumasa

PY - 2007/1/18

Y1 - 2007/1/18

N2 - Human immunodeficiency virus (HIV, lentivirus) vector has attractive features for gene therapy, including the ability to transduce non-dividing cells and long-term transgene expression. We have already reported that lentivirus vector can transduce well-differentiated rat cardiac myocytes. Endothelial cells (EC) are an attractive target for gene therapy, both for the treatment of cardiovascular disease and for the systemic delivery of recombinant gene products directly into the circulation. There are several reports regarding application of adenovirus and retrovirus based vectors to EC. However, there have been few reports which show the effect to lentivirus-mediated gene transfer efficiency, compared with adenovirus and retrovirus. In this study, bovine aortic endothelial cells (BAECs) were infected, in vitro, with these virus vectors. Transduction efficiency (TE) of β-Gal gene transfer in BAECs by adenovirus, lentivirus, or retrovirus at MOI10 (Multiplicity of infection) (determined on Hela cells) is 69±11, 33±8, or 22±6% respectively. In adenovirus and lentivirus, almost 100% of BAECs were transduced at MOI 50. However, in retrovirus, TE showed only 48±6% at MOI 50 and no increase at MOI 100. The percentage of β-Gal positive cells was decreased rapidly at longer passage of cells after being transduced by adenovirus. However, lentivirus and retrovirus showed sustained higher percentage of positive cells. Furthermore, transduction by lentiviral vectors had no significant effect on viability of BAECs. Our results indicate that lentivirus showed high-level and long term gene expression in BAECs. Lentivirus can be an effective vector for the ex vivo, genetically modified EC implantation and in vivo gene therapy.

AB - Human immunodeficiency virus (HIV, lentivirus) vector has attractive features for gene therapy, including the ability to transduce non-dividing cells and long-term transgene expression. We have already reported that lentivirus vector can transduce well-differentiated rat cardiac myocytes. Endothelial cells (EC) are an attractive target for gene therapy, both for the treatment of cardiovascular disease and for the systemic delivery of recombinant gene products directly into the circulation. There are several reports regarding application of adenovirus and retrovirus based vectors to EC. However, there have been few reports which show the effect to lentivirus-mediated gene transfer efficiency, compared with adenovirus and retrovirus. In this study, bovine aortic endothelial cells (BAECs) were infected, in vitro, with these virus vectors. Transduction efficiency (TE) of β-Gal gene transfer in BAECs by adenovirus, lentivirus, or retrovirus at MOI10 (Multiplicity of infection) (determined on Hela cells) is 69±11, 33±8, or 22±6% respectively. In adenovirus and lentivirus, almost 100% of BAECs were transduced at MOI 50. However, in retrovirus, TE showed only 48±6% at MOI 50 and no increase at MOI 100. The percentage of β-Gal positive cells was decreased rapidly at longer passage of cells after being transduced by adenovirus. However, lentivirus and retrovirus showed sustained higher percentage of positive cells. Furthermore, transduction by lentiviral vectors had no significant effect on viability of BAECs. Our results indicate that lentivirus showed high-level and long term gene expression in BAECs. Lentivirus can be an effective vector for the ex vivo, genetically modified EC implantation and in vivo gene therapy.

KW - Adenovirus

KW - Endotherial cells

KW - Gene therapy

KW - Lentivirus

KW - Retrovirus

UR - http://www.scopus.com/inward/record.url?scp=33845437506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845437506&partnerID=8YFLogxK

U2 - 10.1080/10826060601039345

DO - 10.1080/10826060601039345

M3 - Article

C2 - 17134978

AN - SCOPUS:33845437506

VL - 37

SP - 1

EP - 11

JO - Preparative Biochemistry and Biotechnology

JF - Preparative Biochemistry and Biotechnology

SN - 1082-6068

IS - 1

ER -